-
Earlier diagnosis for faster
treatment and better outcome
-
State-of-the-art proprietary
proteomics engine -
Pre-eclampsia: Early diagnosis
prevents adverse outcomes -
Ovarian cancer: Novel diagnostic
tools for advanced care -
Sepsis: Accurate and timely
diagnosis makes the difference -
Cardio-renal syndrome: Unrav-
eling complex disease patterns
Earlier diagnosis for faster treatment and better outcome
Pre-eclampsia
Up to 8% of first time pregnancies are complicated by pre-eclampsia. It is the leading cause of perinatal and maternal mortality. Pronota’s risk stratification test will allow health care providers to personalize neonatal care and prevent many of the adverse outcomes associated with pre-eclampsia.
Sepsis
Current tools for diagnosing sepsis are often uncertain and / or are applied too late. If it is not properly diagnosed, sepsis can cause multiple organ failure and death. Pronota has discovered and verified a set of protein biomarkers that can significantly improve the diagnostic and prognostic accuracy of sepsis.
Ovarian Cancer
One out of 10 women are confronted with a pelvic mass in their lifetime. Up to 20% of these masses can be assigned to malignant ovarian tumors. Pronota’s ovarian cancer test improves pre-surgical risk stratification significantly with a direct impact on the overall outcome.
Cardio-renal Syndrome
The complex pathophysiology of the cardio-renal syndrome makes patient management a major clinical challenge. Pronota’s suite of novel protein biomarkers provides insightful and objective data on the patient’s heart and kidney function, which will allow for more informed therapeutic decisions.
Clinical trial pre-eclampsia product
Recent News
- 18 Apr 2013 Better diagnosis of Acute Heart Failure using Pronota’s novel biomarker
- 09 Apr 2013 Integrated Proteomics Pipeline Yields Novel Biomarkers for Predicting Preeclampsia.
- 05 Nov 2012 International Consortium Awarded €6M to Validate Pre-Eclampsia Early Detection Tests
Events
- Hypertension in Pregnancy European Congress
- International Symposium on Intensive Care and Emergency Medicine
- BIO-Europe Spring 2013
- IMPROvED